|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase Ⅰ evalution of prolonged - infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia 显示文摘 | Rizzieri DA Bass AJ Rosner GL | 2002 | J Clin Oncol2002，20，3： | 1 |
| 2 | Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251显示文摘 | Rizzieri DA Johnson JL Niedzwiecki D | 2004 | Cancer2004，100，7： | 1 |
| 3 | Successful allergenic engraftment of mismatched unrelated cord blood following a nonmveloa hlative preparative regimen显示文摘 | Rizzieri DA Long GD Vredenburgh JJ | 2001 | Blood2001，98，12： | 1 |
| 4 | A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies 显示文摘 | RIZZIERI DA FELDMAN E DIPERSIO JF | 2008 | Clin Cancer Res2008，14，9： | 1 |
| 5 | Leukemic stem cells : a review 显示文摘 | O' Brien JA Rizzieri DA | 2013 | Cancer Invest2013，31，4： | 1 |
| 6 | Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma :final results of Cancer and Leukemia Group B Study 9251显示文摘 | Rizzieri DA Johnson JL Niedzwiecki D | 2004 | Cancer2004，100，7： | 1 |
| 7 | Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation显示文摘 | Rizzieri DA Storms R Chen DF | 2010 | Biol Blood Marrow Transplant2010，16，： | 1 |
| 8 | Pilot trial of thalidomide post - autologous peripheral blood progenitor cell transplantion PBPC in patients with metastaticbreast cancer(abstract) 显示文摘 | Verdenburgh J Rizzieri DA | 1998 | Proc Annu Meet Am Soc Clin Oncol1998，17，： | 1 |
| 9 | Umbilical cord blood expansion with nicotinamide provides long- term multilineage engraftment 显示文摘 | Horwitz ME Chao N J Rizzieri DA | 2014 | J Clin Invest2014，124，7： | 1 |
| 10 | Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells显示文摘 | Guzman ML Neering SJ Upchurch D Grimes B Howard DS Rizzieri DA | 2001 | Blood2001，98，8： | 1 |
| 11 | Partiallymatched,nonmy-eloablative allogeneic transplantation:clinical outcomes and im-mune reconstitution显示文摘 | Rizzieri DA Koh LP Long GD | 2007 | J Clin Oncol2007，25，6： | 1 |
| 12 | A phase 2 clinical trial of AP23573, a mTOR inhibitor, in patients with relapsed or refractory hematologic malignancies( abs 2980 ) 显示文摘 | Rizzieri DA Feldman E Moore JO | 2005 | Blood2005，106，111： | 1 |
| 13 | Partially matched,nonmyeloablative allogeneic transplantation:clinical outcomes and immune reconstitution显示文摘 | Rizzieri DA Koh LP Long GD | 2007 | J Clin Oncol2007，25，： | 1 |
| 14 | Partially matched,nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution显示文摘 | Rizzieri DA Koh LP Long GD | 2007 | J Clin Oncol2007，25，6： | 1 |
| 15 | PhaseⅠevaluation ofprolonged-infusion gemcitabine with mitoxantrone for relapsed orrefractory acute leukemia显示文摘 | Rizzieri DA Bass AJ Rosner GL | 2002 | J Clin Oncol2002，20，3： | 1 |
| 16 | Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution显示文摘 | Rizzieri DA Koh LP Long GD | 2007 | J Clin Oncol2007，25，6： | 1 |
| 17 | Partially matched,nonmyeloablative allogeneic transplantation:clinical outcomes and immune reconstitution显示文摘 | Rizzieri DA Koh LP Long GD | | 0，，06： | 1 |
| 18 | Elacytarabine hassingle-agent activity in patients with advanced acutemyeloid leukaemia显示文摘 | O’Brien S Rizzieri DA Yey N | 2012 | Br J Haematol2012，158，5： | 1 |
| 19 | A phase 2clinical trial of deforolimus(AP23573,MK-8669),a novel mammalian target of rapamycin inhibitor,in patients with relapsed or refractory hematologic malignancies显示文摘 | Rizzieri DA Feldman E Dipersio JF | 2008 | Clin Cancer Res2008，14，： | 1 |
| 20 | Campath-1 H,T-cell depletednonmyeloablative peripheral blood stem cell transplantationfrom 3-6/6Hla matched family members显示文摘 | Koh LP Rizzieri DA Long GD | 2002 | Blood2002，100，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员